3,4-methylenedioxyamphetamine has been researched along with Consciousness, Loss of in 3 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maxwell, DL | 1 |
| Polkey, MI | 1 |
| Henry, JA | 1 |
| Stell, JM | 1 |
| Ryan, JM | 1 |
| Schafer, R | 1 |
3 other studies available for 3,4-methylenedioxyamphetamine and Consciousness, Loss of
| Article | Year |
|---|---|
Hyponatraemia and catatonic stupor after taking "ecstasy".
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Catatonia; Designer Drugs; Female; Humans; Hyponatremia; | 1993 |
Ecstasy and neurodegeneration. gamma-Hydroxybutyrate is a new recreational drug that may lead to loss of consciousness.
Topics: 3,4-Methylenedioxyamphetamine; Designer Drugs; Diagnosis, Differential; Humans; Seizures; Sodium Oxy | 1996 |
Cordelia, Lear, and forgiveness.
Topics: Death; Fear; Female; Guilt; Humans; Interpersonal Relations; Literature; Love; Male; Psychoanalytic | 2005 |